What changed in this filing

/stocks — the workspaceLOADING

Item 4. Controls and Procedures

2024-02-13 compared with 2023-08-14 · 12 added, 33 removed, 3 unchanged (94% of the section changed)

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(b) of the Securities

Exchange Act of 1934, as amended, or the Exchange Act, under the direction of the Chief Executive Officer and the Chief Financial

Officer, we have evaluated our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e)) as of the end of the period

covered by this Quarterly Report on Form 10-Q.

Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have

concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this report due to the

material weakness in our internal controls over financial reporting related to our verification process concerning wire transfer

payments to vendors as discussed further below.

Notwithstanding this material weakness, our management has concluded that the financial

statements included elsewhere in this Quarterly Report present fairly, in all material respects, our financial position, results of operations

and cash flows in conformity with generally accepted accounting principles.

In January 2023, we became aware that we had been

a victim of a criminal fraud that law enforcement authorities refer to as business email compromise fraud, which involved impersonation

of our vendor and fraudulent demands for wire transfers that targeted our finance department.

The fraud resulted in a loss of approximately

$0.1 million.

The Company’s investigation into this matter continues as further discussed in Item 1A.

During the second fiscal quarter of 2023, enhancements

were made to our controls relating to electronic payments, including by wire transfer of funds.

These enhancements include additional

verification and documentation procedures to be followed prior to the initiation or approval of electronic payments by or for us.

these enhancements increase the ability of our personnel to identify and block attempts by third parties to fraudulently initiate electronic

payments from us.

Our management believes that the foregoing actions will help improve our internal controls over financial reporting.

We are actively working to implement effective internal control over financial reporting, which includes remediation of the material weakness.

However, such compliance is not guaranteed, and we cannot provide any assurance that our internal control over financial reporting will

be effective as a result of these efforts.

Changes in Internal Control over Financial

Other than the identification of the material

weakness described above, there has not been any change in our internal control over financial reporting (as such term is defined in Rule 13a-15(f) and 15d-15(f) under

of Disclosure Controls and Procedures

required by Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, under the direction

of the Chief Executive Officer and the Chief Financial Officer, we have evaluated our disclosure controls and procedures as of the end

of the period covered by this Quarterly Report on Form 10-Q.

Based on this evaluation, our Chief Executive Officer and our Chief Financial

Officer have concluded that our disclosure controls and procedures are effective as of the end of the period covered by this report.

Our management has concluded that the financial statements included elsewhere in this Quarterly Report present fairly, in all material

respects, our financial position, results of operations and cash flows in conformity with generally accepted accounting principles.

in Internal Control over Financial Reporting

has not been any change in our internal control over financial reporting (as such term is defined in Rule 13a-15(f) and 15d-15(f) under

the Exchange Act) during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably

likely to materially affect our internal control over financial reporting.

NeuroOne Medical Technologies

PART II – OTHER INFORMATION

Medical Technologies Corporation

II – OTHER INFORMATION

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 4. Controls and Procedures